TABLE 2.

Correlation between TAZ expression and clinical characteristics of LP patients.

Clinical features		TAZ Expression grade				Correlation coefficent	p
		–	+	++	+++
Gender						−0.094	0.129
	Male	24	45	61	28
	Female	25	28	36	15
Age(f)						−0.14	0.822
	0–29	9	14	20	3
	30–60	28	43	60	33
	60+	12	16	17	7
Duration(m)						−0.025	0.684
	≤12	39	58	77	36
	>12	10	15	20	7
Location						0.242	0.000 ***
	Skin	10	14	29	10
	Mucosa	6	24	32	29
	Hair	10	7	8	0
	Nail	9	9	5	2
	Vulva	14	19	23	2
Clinical phenotype						0.0581	0.000 ***
	Erosive	42	35	12	3
	Non‐erosive	7	38	85	40
Smoking and alcohol habits						0.125	0.043 *
	Yes	18	38	53	25
	No	31	35	44	18
Treatment history						0.027	0.667
	Yes	16	28	36	12
	No	33	45	61	31
Symptoms						0.100	0.105
	Yes	15	26	49	16
	No	34	47	48	27

P < 0.005; ***P < 0.01.